AMWA Advocacy

Advocacy Timeline


July 9, 2024 – AMWA signs on to letter Opposing NIH Restructuring in the House Labor-HHS Bill including funding for women’s health research

June 12, 2024 – AMWA signs on to letter drafted by NDWA and MomRising together with CLASP and the Immigration Hub urging President Biden to take swift positive action to protect immigrant caregivers, care workers and their families

June 12, 2024 – The Improving Seniors’ Timely Access to Care (Seniors’) Act was introduced in the House and Senate on Wednesday, June 12, 2024. The Senate bill number is S. 4532, and the House is H.R. 8702. AMWA is one of almost 400 organizations endorsing the legislation. See section by section summary and list of endorsing organizations.

June 7, 2024 – AMWA signed on to the LEAD Coalition letter to the FDA and its advisory committee regarding the review of donanemabThe letter does not take a position for or against approval. Instead, the letter focuses on the need for disease-modifying therapeutics for individuals with early symptomatic Alzheimer’s disease and includes a brief discussion of findings from the Phase III results that are likely to be meaningful to individuals living with Alzheimer’s disease and their families.

June 6, 2024 – AMWA writes letter to Chairs of the Ways and Means Committee of the House encouraging the Treat and Reduce Obesity Act be considered in the next mark-up session. Also in June, AMWA sent letters to key members of the Ways and Means Committee urging their support for obesity coverage in the upcoming health markup session.

June 2024 – AMWA signs on to letter, joining national, state, and local organizations to urge the House and Senate to develop a Farm Bill that ensures that the Supplemental Nutrition Assistance Program (SNAP) is protected and strengthened and that benefit adequacy, equitable access, and program administration remain core tenets of the program.

May 31, 2024 – AMWA signs on to APHA letter to Select Subcommittee on Select Subcommittee on the Coronavirus Pandemic the Coronavirus Pandemic Committee on Oversight and Accountability to show broad support for public health

May 14, 2024 – AMWA signs on to letter supporting government funding for Social Determinants of Health

May 3, 2024 – AMWA signs on to letter to the Senate and House Appropriation Committees encouraging continued funding to advance the science to deliver even more effective treatments for Alzheimer’s disease and related disorders, improve access to timely and accurate diagnosis, strengthen programmatic supports imperative to quality of life for people with dementia and their caregivers, and expand public health capacity to reduce incidence and prevalence of these diseases

May 2024 – AMWA signs on to letter as part of the Campaign for Tobacco-Free Kids urging stronger enforcement against unauthorized e-cigarette products

May 2024 – AMWA signs on to Safe Step Act Ad Hoc Coalition letter urging the Education & Workforce Committee to mark up the Safe Step Act in response to the ERISA 50th anniversary hearing.

May 2024 – AMWA signs on to letter supporting Medicare coverage for GLP1s and IBT for obesity management

April 24, 2024 – AMWA participates in a letter offering consensus recommendations in response to the White House Initiative on Women’s Health Research

April 11, 2024 – AMWA signs on to second letter to President Biden and his White House Cancer Moonshot team urging them to take action that would help ensure 90 percent of individuals are vaccinated against HPV, a key milestone in the mission to eliminate cervical cancer as a public health problem and end cancer as we know it.

April 17, 2024 – AMWA signs on to letter to Congress regarding FY25 Appropriations encouraging funding for women’s health across all agencies.

April 4, 2024 – AMWA signs onto letter supporting the VOCA Victim Compensation guidelines. If implemented, the proposed federal rule will be a significant step to removing critical barriers to violence survivors and offering greater support to families in their most vulnerable moments. We have an important opportunity to express support for the proposed rule and ensure violence survivors have access to compensation to help recover physically, financially, and emotionally.

April 1, 2024 – AMWA signs onto the Friends of ORWH fiscal year 2025 funding request letter asking lawmakers for at least $153.9 million in base funding for ORWH in fiscal year 2025 for women’s health research

April 2024 – AMWA signs on to letter endorsing funding to support research targeted to women’s health technology innovations

April 2024 – AMWA signs on to letter with AAP and other medical, public health, and research organizations supporting funding for gun violence prevention research for FY25

April 2024 – AMWA signs on to letter to the Ways & Means Committee urging them to mark up the Treat and Reduce Obesity Act (H.R. 4818)

April 2024 – AMWA signs on to ACOG Letter regarding case before the Supreme Court about EMTALA and abortion care

April 2024 – AMWA signs on to Association of Maternal & Child Health Programs letter in support of Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET) for 2025 fiscal year

April 2024 – AMWA signs on to letter supporting the Raising Awareness for Youth Suicide Prevention (RAYS) Act, which would require middle and high schools that receive federal funding to include suicide prevention and crisis intervention information such as the 988 Lifeline on school IDs

March 12, 2024 – AMWA signs on to letter urging Congress to pass H.R.4184 and S.2048, the Equal Access to Justice for Victims of Gun Violence Act to repeal the Protection of Lawful Commerce in Arms Act (PLCAA) to ensure that the survivors of gun violence will be allowed to have their day in court and the gun manufacturers, sellers and interest groups are not shielded from liability when it acts with negligence and disregard for public safety.

March 2024 –AMWA signed on to EMTALA Amicus Brief submitted and accepted by the US Supreme Court with signatories: American Public Health Association Robert Wood Johnson Foundation, Network for Public Health Law, and 133 Deans and Scholars as Amici Curiae in Support of the Federal Government vs Idaho

March 2024 – AMWA signs on to HealthyWomen HPV Coalition Letter to Congress supporting the PREVENT HPV Cancers Act – H.R. 3633

March 2024 – AMWA signs on the GVP Research Roundtable FY 2025 Appropriations letter calling on Congress to provide $35 million for the CDC, $25 million for the NIH, and $1 million at the NIJ for this critical research in FY25. These asks for CDC and NIH are aligned with President Biden’s FY25 budget request.

March 2024 – AMWA Joining Joint Statement Urging the Biden Administration to Immediately Issue Final Rules Prohibiting Menthol Cigarettes and Flavored Cigars (Draft Statement)

March 2024 – AMWA signs on to letter supporting GenBioPro’s challenge to a West Virginia law that currently blocks patients in West Virginia from accessing mifepristone, an essential U.S. Food and Drug Administration (FDA)-approved abortion medication.

March 2024 – AMWA signs on to letter organized by The GME Advocacy Coalition in support of the Substance Use Disorder Workforce Act (H.R. 7050) that was introduced last month by Reps. Schneider, Kuster, Valadao, Carey, and Kelly. This bipartisan legislation would make available 1,000 new Medicare-supported residency positions to hospitals that have — or are in the process of establishing — approved residency programs in addiction medicine, addiction psychiatry, or pain medicine and their prerequisite programs.

February 16, 2024 — AMWA sends letter to the Congressional Budget Office supporting the Preventative Health Savings Act, which would allow more accurate CBO scoring to take into account the long-term economic impact of interventions and a letter of thanks to Congressman Burgess

February 2024 – AMWA signs on to letter in support of Congress passing the PAHPA reauthorization which expired in Sept 2023

February 2024 – AMWA signs on letter that supports funding for the Division of Adolescent School Health and the Teen Pregnancy Prevention Program – currently the only evidence-based federal programs around sex education

January 30, 2024 – AMWA signs on to Amicus Brief for FDA vs Alliance for Hippocratic Medicine with strong interest in protecting the autonomy of patients and clinicians evidence-based medical care and support of continued evidence-based use of mifepristone; the Amicus has been submitted to and accepted; this has been submitted to and accepted by the Supreme Court of the United States.

January 22, 2024 – AMWA joins thank you letter to the US Senate for designating September as “National Cholesterol Education Month” and September 30 as “LDL-C Awareness Day.”

January 17, 2024 – AMWA signs on to letter asking Congress to reverse the 3.4% Medicare physician fee cut for 2024

January 9, 2024 – AMWA signs on to Tobacco Free Kids Campaign letter as part of Senate Appropriations Bill

January 8, 2024 – AMWA wrote letter expressing our support for CMS’s consideration of moving from USP Medicare Model Guidelines (MMG) to the USP Drug Classification (USP DC) system for use in the essential health benefit (EHB) package which would improve access to treatment for obesity and infertility

January 3, 2024 – AMWA wrote letter to the CA Senate Health Committee supporting SB839–the Obesity Treatment Parity Act

January 2024 – AMWA joins Amicus Brief for Gen Bio Pro vs. State of West Virginia, a case about advance provision of abortion medications before pregnancy occurs

January 2024 – AMWA signs on to the FY24 Maternal Health Coalition Letter supporting efforts to include the PREEMIE Reauthorization Act (H.R. 3226/S. 1573) and the Preventing Maternal Deaths Reauthorization Act (H.R. 3838/S. 2415) in the final FY 2024 appropriations package

January 2024 – AMWA signs on to letter calling on Congress to reject a full year CR that will significantly cut NDD appropriations and instead adopt the bipartisan Senate funding framework as a starting point for final negotiations

January 2024 – AMWA signed on to a letter proposing legislation that would require EMR’s to include a section focused on screening for risk of gun injury


December 2023 – AMWA joins campaign to prohibit flavored tobacco products

December 2023 – AMWA signs on to letter to President Biden urging publication of the Equal Rights Amendment

November 21, 2023 – AMWA joins amicus brief with ACOG and other medical organization in the 353rd Judicial District Court of Travis County stating clinicians must be able to provide abortions where indicated for pregnant patients experiencing health- or life-threatening medical conditions

November 16, 2023 – AMWA signs on to AMA letter to US House and Senate leadership asking to cancel Medicare cuts

November 14, 2023 – AMWA signs on to letter to the US House and Senate encouraging passage of the Treat and Reduce Obesity Act (TROA), designed to effectively treat and reduce the harmful impact of obesity in older Americans

November 9, 2023 – AMWA joins Friends of ORWH in a Letter to lawmakers encouraging them to expeditiously pass fiscal year 2024 appropriations legislation and to include at least the Senate’s recommended funding level of $47.8 billion for the NIH and at least $71.4 million for the ORWH’s base budget.

November 2023 – AMWA joins the 11th Sandy Hook Anniversary Sign-On Letter asking Congress for support of gun safety legislation

November 2023 – AMWA signs on the the National Women’s Law Center letter to Senate and House Leadership Urging No Cuts, No Shutdown and No Harmful Riders that will adversely impact women, children, and LGBTQI+ people. including funding for child care and WIC.

November 2023 – AMWA takes the Count Us In pledge organized by the Human Rights Campaign to support transgender and non-binary children and youth

November 2023 – AMWA signs on to letter that addresses two technical changes to the Inflation Reduction Act’ orphan drug exclusion that will help preserve the hope of the 95% of rare disease communities without disease-specific FDA approved treatment options, while not changing the number of approved indications a product can have before becoming eligible for Medicare negotiation.

November 2023AMWA organized meetings with Congressional Representative Offices and other stakeholders (National Association of Nurse Practitioners in Women’s Health, Association of Black Cardiologists, National Association of Nurse Practitioners in Women’s Health) to discuss the Treat and Reduce Obesity Act and the need to address obesity as a chronic disease.

  • Meeting with the office of Rep. Pallone, Chairman – House Committee on Energy and Commerce
  • Meeting with the office of Rep. Neal, Chairman – House Ways and Means Committee
  • Meeting with the office of Speaker Nancy Pelosi

October 26, 2023 – AMWA joins amicus brief in a matter being appealed to the Seventh Circuit out of the Eastern District of Wisconsin pertaining to a challenge to a school policy that prevents transgender girls from using school bathrooms that comport with their gender identity

October 26, 2023 – AMWA signs on to letter to the US Senate in campaign against assault weapons

October 23, 2023 – AMWA Issues Statement in Aftermath of Mass Shooting in Lewiston, Maine
The American Medical Women’s Association is deeply saddened by the mass shooting in Lewiston, Maine – adding to the growing death toll from firearms in the US. As physicians and public health practitioners, we know that firearm injuries are preventable with responsible gun safety legislation. AMWA urges Congress to co-sponsor and vote for universal background checks, renewal of the assault weapon ban, and federal red flag laws. before more loved ones die unnecessarily. Our hearts are with the families of the victims, the healthcare workers, and the communities near and far struggling in the wake of this horrific shooting.

October 16, 2023 – AMWA wrote letter advocating for House resolution on Cholesterol Awareness Month and LDL Awareness Day

October 2023 – AMWA joins letter of support for National Injury Prevention Day on November 18

October 2023 – AMWA joins letter to legislators encouraging appropriations for maternal mental health

September 27, 2023 – AMWA signs on to LEAD Coalition letter asking Congress to pass the CHANGE Act (S.2379 / H.R.4752) to improve dementia detection

September 27, 2023 – AMWA Issues Statement on Abortion Bans and Impact on Treatment for Pregnancy Complications
Lawsuits in Idaho, Tennessee, and Oklahoma highlight significant gaps in the medical care of pregnant women where restrictive state bans may limit treatment for a pregnancy complications, as practitioners are fearful of violating the law. Yet we know that medicine is not a perfect science. It can be impossible to identify the exact time when a patient’s condition shifts from stable to life-threatening, at which time, an abortion might then be legal. One need only review cases presented during morbidity and mortality rounds to know that physicians can’t reliably make those predictions. As one plaintiff stated, “It’s not safe to be pregnant in Oklahoma.” These cases reinforce the fact that the question of whether an abortion should or should not be performed is not just a religious, political, or ideological question. It is a medical question.

“As a physician practicing in Tennessee, I have witnessed the immense stress my colleagues have been burdened with, trying to care for their pregnant patients while ensuring they are not breaking the law. It’s a difficult position to be placed in, to know the correct treatment for your patient but to be unable to provide evidence based, compassionate healthcare to someone having a pregnancy complication. I applaud the bravery of the physicians and patients bringing light to the heartbreaking situations they have faced and I will continue to advocate for comprehensive reproductive healthcare access in every state.” – Katrina Green, MD, Co-chair of the AMWA advocacy committee.

AMWA President, Elizabeth Garner, MD, MPH concurred. “These cases highlight the challenges that physicians face when trying to navigate the complexities of patient care within constraints of these laws, often having to make decisions that are not the standard of care and risking charges of malpractice in order to comply with the law.”

September 26, 2023 – AMWA Warns that a Government Shutdown Will Harm Patients
A government shutdown by Congress will have far reaching impacts on the healthcare of communities across the country, particularly among under-resourced communities that rely on federal aid In addition, a shutdown would affect the infrastructure of our transportation systems, agricultural supplies, public safety, national security, and more. A recentWhite House analysis showed the devastating impact on the WIC program, if this were to occur. The state-by-state breakdown of the number of women, infants, and children at risk of losing critical nutrition assistance totaled more than 6.6 million.

AMWA urges Congress to find consensus on legislation that will avert a government shutdown and preserve essential funding to vital health programs providing aid to the most vulnerable. Our patients deserve no less.

September 22, 2023 – AMWA signs on to letter urging Gov Gavin Newsome to sign SB 541 into law, which would support youth health and wellness, promote health equity, and curb STI transmission among California youth by providing free condoms in public high schools.

September 20, 2023 – AMWA supports Congressional resolution on September cholesterol education month and September 30 as LDL Awareness Day

September 20, 2023 – AMWA signs on to letter to Congressional Appropriators, urging Congress to include sufficient resources in a short-term Continuing Resolution to ensure that WIC can continue providing all eligible women, infants, and children who seek to participate with the full, science-based nutrition benefit. The letter also calls on Congress to fully fund WIC for fiscal year 2024 to sustain current benefits and increasing participation.

September 19, 2023 – AMWA joined with the National Association of Nutrition and Aging Services Programs (NANASP) in a call with the CDC to discuss the RSV vaccination recommendations under the current shared decision making model.

September 18, 2023 – AMWA writes letter of support to California State Legislators in support of California SB345 that would establish a shield law in California, protecting practitioners who provide reproductive healthcare, including telehealth, to patients from states with restrictive bans.

September 18, 2023 – AMWA joins with the American Lung Cancer Screening Initiative and other organizations, sending a letter encouraging the U.S. Congress to place a notice about lung cancer screening on cigarette packages.

September 14, 2023 – AMWA joins The ABC3 Coalition to endorse the National Roadmap for Disability-Inclusive

September 12, 2023 – AMWA joins G02 supporting bills S.2245 and H.R.4534, the Women and Lung Cancer Research and Preventive Services Act of 2023

September 6, 2023 – AMWA signs on to Washington Post Ad Campaign with Tobacco-Free Kids, the American Heart Association, and other groups in support of the proposed rules to prohibit menthol cigarettes and favored cigars.

September 2023 – AMWA sends letters to Congress expressing concerns with the CY 2024 Hospital Outpatient Prospective Payment System (OPPS) proposed rule as published in the Federal Register on July 31, 2023 for missing an opportunity to dramatically increase patient and provider access to non-opioid pain management approaches and, in the process, prevent opioid addiction.

August 29, 2023 – AMWA signs on toe a letter urging CMS to accelerate the use of non-opioid pain management approaches in outpatient surgery settings.

August 30, 2023 – AMWA joins the First Focus on Children and the Children’s Defense Fund in supporting the Child Poverty Reduction Act which would establish a national child poverty reduction target in the United States, setting an official goal to cut child poverty in half within a decade.

August 10, 2023 – AMWA sends letter of support for Assembly Bill 1028. This important legislation will modernize California’s medical mandated reporting law for adult violent injuries to better ensure safety and healthcare access for survivors of domestic, sexual, and interpersonal violence.

August 10, 2023 – AMWA sends letters to US Senate Joint Economic Commission members, urging the coverage of medications for the treatment of obesity and supports the Treat and Reduce Obesity Act (TROA)

August 7, 2023 – Gun violence has been the leading cause of death of children in America since 2020, making it a public health crisis. AMWA endorses the House Gun Violence Prevention Task Force call for a vote in support of gun violence prevention legislation.

August 2023 – AMWA with the office of Nanette Barragán to discuss the Treat and Reduce Obesity Act and women’s health initiatives.

August 2023 – AMWA sends letter to the Director of Centers for Disease Control and Prevention asking to work in partnership to ensure older Americans remain a priority when it comes to the prevention and treatment of illness and disease

July 26, 2023 – AMWA signs on to letter supporting an amendment that would strike down a provision in the FY-24 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations bill that would undermine access to mifepristone.

July 16, 2023 – To enforce gender equity through legislation, AMWA endorses the ERA Now Resolution introduced by Senator Kirsten Gillibrand (with a companion resolution introduced by Congresswoman Cori Bush) to affirm the Equal Rights Amendment (ERA) as the 28th Amendment to the Constitution.

July 2023 – AMWA supported the South Asian Heart Health Research and Awareness Act, being reintroduced by Congresswoman Jayapal in the House

July 2023 – AMWA signs on to letter opposing attacks on medication abortion in House Appropriations bill

June 29, 2023 – AMWA sends letter to California legislators in support of SB 345 which will help ensure the availability of abortion and gender affirming care by providing additional protections to providers who prescribe or dispense medication abortion, provide other reproductive health care services, or provide gender affirming care regardless of where their patients live.

June 28, 2023 – AMWA signs in support for LaRose v. King County in the Washington State Court of Appeals, filed by the National Women’s Law Center, regarding workplace harassment standards.

June 28, 2023 – AMWA joined more than 360 LEAD Coalition member organizations and allies sent a joint letter to Congress reiterating support for dementia-focused FY 2024 appropriations priorities communicated earlier this year by the health, aging, and science advocacy community

June 28, 2023 – AMWA signs on with the many other medical organizations to the Democracy Forward Foundation amicus curiae brief in the Fifth Circuit in support of the motion for stay pending appeal in Braidwood Management Inc. v. Becerra, regarding the repercussions that a nationwide stay could have on the availability of no-cost preventive care under the Affordable Care Act.

June 26, 2023 – AMWA endorses the updated Position Statement on Nonhormone therapy for treatment of Vasomotor Symptoms of Menopause, published by the North American Menopause Society.

June 24, 2023 – AMWA joins a rally in Charlotte, NC with Vice President Kamala Harris on the one year anniversary of the ruling in Dobbs v. Jackson Women’s Health Organization which overturned Roe v. Wade.

June 23, 2023 – AMWA endorses President Biden’s Executive Order on Strengthening Access to Contraception. Read the entire Executive Order

On the eve of the first anniversary of the Dobbs decision, President Biden issues an important and timely Executive Order that focuses on expanding access to affordable contraception as a critical element of reproductive care. AMWA champions this 3-pronged effort to address a growing concern for individuals who currently use contraceptives throughout the United States. It’s important to emphasize that while the majority of individuals rely on contraception for family planning, there are other medical indications for the use of  these modalities.

The order identifies actions in several critical ways:

  • Seeking to assure that every Food and Drug Administration-approved, -granted, or -cleared contraceptives and the care needed to obtain contraception is covered both by private health insurance under the Affordable Care Act (with no cost sharing) and through improved coverage of all federally-funded programs and to expand access to over-the-counter contraceptives, thereby reducing barriers that women face in accessing contraception.
  • Sharing best practices with employers and institutions of higher education to assure that employees and students are aware of their options to obtain contraception.
  • Promoting expansion of research and data analysis to identify  gaps and disparities in contraception access and the benefits of comprehensive coverage

June 22, 2022 – AMWA signed onto amicus brief for LaRose v. King County, filed by the National Women’s Law Center regarding workplace harassment standards

June 14, 2023 – AMWA submits comments on the U.S. Preventive Services Task Force Obesity Research Plan that advocate for more increase access to obesity therapeutics.

June 8, 2023 – AMWA joins over 240 LEAD Coalition member organizations and allies in a joint public comment letter to the U.S. Centers for Medicare and Medicaid Services (CMS) expressing strong support for inclusion of the Geriatrics Hospital Measure and the Geriatrics Surgical Measure in the CMS Hospital Inpatient Quality Reporting (IQR) Program (proposed rule CMS-1785-P)

June 2023 – AMWA sends letter supporting California SB345 (Skinner), being heard in the Assembly Judiciary Committee, will help ensure the availability of abortion and gender affirming care by providing additional protections to providers who prescribe or dispense medication abortion, provide other reproductive health care services, or provide gender affirming care regardless of where their patients live

June 2023 – AMWA signs on with the many other medical organizations to the Democracy Forward Foundation amicus curiae brief in the Fifth Circuit in support of the motion for stay pending appeal in Braidwood Management Inc. v. Becerra, regarding the repercussions that a nationwide stay could have on the availability of no-cost preventive care under the Affordable Care Act.

June 2023 – AMWA signs on to letter to the FDA advisory committee about its review of lecanemab

June 2023 – AMWA endorses the Right to Contraception Act reintroduced on June 14 to protect the federal right to contraception and the information made available for individuals to make safe, informed decisions about their reproductive health.

June 2023 – AMWA signs with Trust For America’s Health in endorsement of the Improving the Social Determinants of Health Act being reintroduced in the 118th Congress.

June 2023 – AMWA observes June as Gun Violence Awareness Month and acknowledges the importance of physician advocacy in the prevention of firearm related harm, both in and outside the exam room. Gun violence is a public health crisis and AMWA supports a multipronged evidence informed approach, including research, education, and legislative advocacy. As physicians and medical students from an array of backgrounds and practicing in a multitude of specialties, AMWA members routinely care for patients impacted by gun violence and are in a unique position to advocate for improved health and safety of communities, from rural to urban, throughout the United States.

May 12, 2023 – AMWA sends letter to Senators in support of Nationnal Fentanyl Awareness Week highlighting AMWA’s work in addressing counterfeit drugs and the opioid addiction crisis.

May 2023 – AMWA joins the Campaign Against Assault Weapons through the Newtown Action Alliance and signs the letter to President Biden and members of Congress asking for a federal ban on military-style semi-automatic assault weapons.

May 2023 – AMWA signs on to the Coalition for Human Needs letter asking Congress to say NO to cuts to the social safety net, including SNAP benefits, the WIC program, Medicaid, Head Start, childcare, substance use disorder treatment, and mental health programs.

May 2023 – AMWA supports over the counter (OTC) progestin-only hormonal contraception in the U.S. without a prescription to improve reproductive care of women and those capable of becoming pregnant and asks the FDA to approve its use.

May 2023 – AMWA supports the Senate reintroducing National Fentanyl Awareness Day on May 9, aligning with our important work in raising awareness of counterfeit drugs and addressing opioid addiction in women.

May 2023 – AMWA supports the resolution of the American College of Radiology (ACR) to oppose any government regulation or legislative action that would criminalize physicians and other medical imaging professionals for providing evidence-based medical care within the scope of their training, professional judgment, and nationally recognized professional practice guidelines.

May 2023 – AMWA joined an amicus brief concerning the parameters of workplace civil rights protections, specifically for survivors or other victims of harassment in connection with third party harassers

May 2023 – AMWA joins the LEAD Coalition (Leaders Engaged on Alzheimer’s Disease) in letter to CMS supporting the addition of geriatric medicine and surgical quality measures for hospitals.

May 2023 – AMWA signs on to letter to Congress opposing cuts to non-defense discretionary appropriations – cuts that would harm funding for many public health programs including ones at HRSA

May 2023 – AMWA signs on to Healthy Women and HPV Cancers Alliance letter to the White House on its relaunched Cancer Moonshot effort regarding the essential importance of the HPV vaccine to cervical cancer reduction.

May 2023 – AMWA signs on to the Alliance for Women’s Health & Prevention (AWHP) letter asking the Administration to do everything possible to defend, preserve and protect key preventive services coverage including screenings for cancer and other chronic diseases, as well as certain pregnancy care services

April 28, 2023 – AMWA joins amicus brief in the Fifth Circuit Court to maintain the ACA’s preventive care coverage requirements

April 19, 2023 – AMWA signs onto a letter expressing support for the H.R. 2474, the Strengthening Medicare for Patients and Providers Act. This bipartisan legislation advances the ongoing need to provide financial stability to physician practices in order to preserve access to care for Medicare beneficiaries.

April 19, 2023 – AMWA signs on to this year’s Gun Violence Prevention (GVP) Research Roundtable FY 2024 appropriations letter. The letter calls on Congress to provide $35m for CDC and $25m for NIH, and for the first time calls for Congress to continue the $1m at the National Institute of Justice (NIJ) for this critical research.

April 13, 2023 – AMWA signs on to a letter to US Labor, Health and Human Services, Education and Related Agencies appropriations leaders requesting $100 million for the CDC’s Social Determinants of Health (SDOH) program to ensure that public health departments, academic institutions, and nonprofit organizations are properly supported to address the social determinants of health in their communities.

April 7, 2023 — AMWA strongly opposes the Texas decision to suspect FDA approval of mifepristone.

April 3, 2023 – AMWA joins an amicus brief in the Fourth Circuit in support of a trans student denied the ability to participate in school sports teams that correspond to her gender identity as a result of a newly adopted law in West Virginia

April 3, 2023 – AMWA joins amicus brief with the 5th Circuit in support of FDA’s approval of the use of mifepristone to end a pregnancy through ten weeks gestation

April 2023 – AMWA joins UsAgainstAlzheimer in asking Congress to adequately support the Alzheimer’s Disease and Healthy Aging Program

April 2023 – AMWA has joined the coalition of medical organizations endorsing the Congressional Hepatitis Caucus in reintroducing the resolution designating April 30th as National Adult Hepatitis B Vaccination Awareness Day.

April 2023 – AMWA joins a nonpartisan coalition to support a reasonable response to the gun violence in Tennessee, signing onto a letter to Tennessee Governor Bill Lee and members of the TN General Assembly, urging the passage of gun safety legislation.

March 23, 2023 – AMWA joins an appropriations request letter asking for $10.5 billion in HRSA discretionary funding in FY 2024

March 15, 2023 – AMWA signs on to letter to Congress supporting anticipated MedPAC recommendation to highlight the urgent need to pass legislation that provides for an annual inflation-based payment update for physicians based on the full MEI

March 2023 – AMWA is signing on to the White House/HHS Health Sector Climate Pledge. By signing on, AMWA commits to emissions reduction and climate resilience goals.

March 2023 – AMWA signs on to letter to lead appropriators in Congress seeking an adequate share of funding for Labor-Health and Human Services-Education appropriations in FY 2024

March 2023 – AMWA signs on to a fiscal year 2024 appropriations funding letter to support funding of the Office of Research on Women’s Health (ORWH)

March 2023 – AMWA joins coalition to safeguard public health by signing a letter of support for SB 616, a bill to require California employers to provide 7 paid sick days per year.

March 2023 – AMWA signs on to letter to fund the Title V Maternal & Child Health Block Grant at $1 billion in FY24

March 2023 – AMWA signs on to letter supporting funding the CDC surveillance for emerging threats to mothers and babies (SET-NET) program at $100 million in FY24

March 2023 – AMWA sent letter supporting the Bipartisan Background Check bill

March 2023 – Statement Issued: The American Medical Women’s Association (AMWA) has long advocated for pay equity for all. The recent study by Payscale again documents the inequity that exists for women and BIPOC physicians and surgeons. The survey notes an inequity of $35,000/year, leading up to a projected $900,000 gap for a lifetime of employment. Since 1915, AMWA has worked to bring equity to healthcare at all levels, for patients and for those that serve and care for them. AMWA serves a unique role in advocating for equity in compensation through mentoring, advising, and developing personal comfort when discussing financial matters. AMWA will continue to be a medical organization that advocates for health equity.

March 2023 – Statement Issued: AMWA supports legislation that would help decrease maternal and infant mortality rates such as ensuring access to obstetrical care in rural and underserved areas, increased funding for maternal support services such as doulas, programs to help reduce costs of prenatal and postnatal care, and expansion of maternity and paternity leave benefits.

March 2023 – Statement Issued: AMWA advocates for continued access to healthcare through the Medicare program. We agree with legislation and funding for programs that expand healthcare access. View Fact Sheet

February  17, 2023 — Statement Issued: AMWA is opposed to legal interference that precludes physicians’ ability to practice evidence-based medicine and to prescribe FDA-approved medications, including Mifepristone, to patients as this can lead to preventable adverse consequences.

February 6, 2023 – AMWA signs onto Family Values at Work letter to Congress which calls for federal Paid Family Leave (inclusive, accessible, job-protected) on the 30th anniversary of the passage of the FMLA on February 2nd

February 2, 2023 – AMWA signs on to Tennessee Equality Project’s statement on LGBTQ healthcare

February 2023 – AMWA letter-writing campaign urges Congressional representatives to contact CMS to update Medicare osteoporosis payment policies in the next Physician Fee Service rule, so that people who suffer osteoporotic fractures get the cost-effective care they need to prevent additional fractures. Better post-fracture care for people with osteoporosis will improve the quality of care and can reduce healthcare disparities, opioid use, and nursing home admissions, all while reducing avoidable medical costs.

February 2023 – AMWA gives support for a bill that ACLU and If/When/How are working on to stop the California and other state governments from using reverse warrants, a form of unconstitutional digital surveillance that puts people at grave risk, particularly if they are seeking reproductive care. These so-called “reverse warrants” — “geofence warrants,” or “keyword warrants” — can compel tech companies to search their data banks and reveal the identities of all people who looked up a particular keyword online or drove down a certain street.

February 2023 – Statement Issued: AMWA is opposed to any legal interference that impedes physicians’ ability to practice evidence-based medicine and to prescribe FDA-approved medications, including Mifepristone. The inability to provide essential reproductive healthcare leaves women at increased risk for adverse outcomes.

February 2023 – AMWA endorses the Ad Hoc Group for Medical Research’s FY 2024 recommendation for “at least $50.924 billion for NIH’s foundational work, a $3.465 billion increase over the comparable FY 2023 program level, which would allow NIH’s base budget to keep pace with the biomedical research and development price index (BRDPI) and allow meaningful growth of 5%.” The recommendation also notes the establishment of ARPA-H and adds that, “In addition to the Ad Hoc Group’s FY 2024 recommendation of at least $50.924 billion for NIH’s base budget, many of our organizations also have been engaging ARPA-H and separately support renewing the ARPA-H investment in FY 2024.”

January 31, 2023 – AMWA signs on to TheTimeIsNow GVP Coalition letter sent to President Biden before his State of Union address

January 31, 2023 – AMWA joined the #KeepKidsSafe Coalition to officially support Ethan’s Law

January 31, 2023 – AMWA Supports Resolution to Affirm the Ratification of the Equal Rights Amendment

January 13, 2023 – AMWA supports abortion shield laws. AMWA sent a memorandum to New York Senator Mayer in support of S1066, a bill that would shield clinicians and pharmacists throughout the state from  prosecution, loss of license or malpractice, and from subpoenas of their medical records for prescribing and sending of abortion pills to people who need them

January 2023 – AMWA signs on to Wisconsin Health Professionals for Climate Action’s organizational letter calling for the re-opening of the HHS Health Sector Climate Pledge

January 2023 – AMWA gave support to  a bill introduced in the Illinois legislature in support of publishing the ERA Amendment to codify women’s equality and equal rights, which would also assure access to abortion care